Azetidine → HCID 71525484, Verbindung
Reaktionsgleichung
[CH3:1][C:2]([NH:10][C:11]([C:13]1[CH:18]=[N:17][C:16](Br)=[C:15]([C:20]2[CH:25]=[CH:24][CH:23]=[C:22]([Cl:26])[CH:21]=2)[N:14]=1)=[O:12])([C:4]1[N:8]=[C:7]([CH3:9])[O:6][N:5]=1)[CH3:3].[NH:27]1[CH2:30][CH2:29][CH2:28]1>>[CH3:1][C:2]([NH:10][C:11]([C:13]1[CH:18]=[N:17][C:16]([N:27]2[CH2:30][CH2:29][CH2:28]2)=[C:15]([C:20]2[CH:25]=[CH:24][CH:23]=[C:22]([Cl:26])[CH:21]=2)[N:14]=1)=[O:12])([C:4]1[N:8]=[C:7]([CH3:9])[O:6][N:5]=1)[CH3:3]Komponenten
3
Versuchsvorschrift
The title compound was synthesized in analogy to Example 4, using 5-bromo-6-(3-chloro-phenyl)-pyrazine-2-carboxylic acid [1-methyl-1-(5-methyl-[1,2,4]oxadiazol-3-yl)-ethyl]-amide (Example 1e) and azetidine as starting materials, and isolated (29 mg, 41%) as light yellow oil; MS (EI): 413.2 (M+H).
Aufarbeitung
- customisolated (29 mg, 41%) as light yellow oil
Quellen und Nachweise
- ORD-Eintrag
- ord-8f944dea115740ebb8f638249c45af8e
- Quelldatensatz
- uspto-grants-2016_08